INSIGHTS ON SOLID DOSE MANUFACTURING
-
The Future Of Oral Solid Dose Development And Innovation
Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.
-
Advances In Oral GLP-1 Analogs For Obesity
Discover how these groundbreaking Oral GLP-1 Analogs therapies are reshaping obesity management and addressing key challenges in formulation and delivery.
-
Fundamentals Of Power Blending Simulations
Predicting blending quality doesn't have to be a guessing game. Learn how to leverage virtual prototypes to make informed decisions and minimize costly trial-and-error in tablet manufacturing.
-
Orally-Disintegrating Dosage Forms With Taste Masked Multiparticulates
Learn more about our orally disintegrating tablet (ODT) capabilities and how these innovative technologies have the potential to improve acceptance, adherence, and compliance in pharmacotherapy.
-
How To Avoid Sticking And Picking In The Tableting Industry9/23/2024
Review strategies to mitigate sticking and picking risks in the tablet industry, and learn how you can foster improved tablet production processes, ensuring higher quality and consistency.
-
The Importance Of Polymorph Screenings5/6/2026
Discover how systematic polymorph screening reduces development risk, safeguards product performance, and enables confident solid‑form selection across the drug development lifecycle.
-
Bottling Solutions3/4/2025
Explore a bottling solution that is meticulously engineered to adhere to the most stringent pharmaceutical standards, which guarantees that each product is crafted with unparalleled quality and precision.
-
Tablets And Capsules: Overcoming Similar Obstacles In Production7/30/2024
Explore how understanding specific USP chapters can address common tablet and capsule production challenges and ensure high-quality results in this essential pharmaceutical process.
-
Closing The Duration Gap In FDA-Approved Long-Acting Contraceptives7/17/2024
A gap exists between three months and three years in FDA-approved long-acting contraceptives (LACs). A microsphere formulation enables sustained release over a six to twelve-month period.
SOLID DOSE MANUFACTURING SOLUTIONS
-
Used MG2 Planeta 100 continuous motion capsule filler with touch screen HMI, vacuum system, serial# 4661, built 2010.
-
Used BellatRx electronic lane counter, model RX-Fill PLUS, speeds up to 25 bottles/minute at 100 count, 2-40mm tablet size, 1" - 4" by 12" high bottle size, 0.5" or larger neck diameter, Allen Bradley PLC controls with PanelView 600 HMI, 120 volt, order# 7155, serial# 035, built 2019.
-
Used 79 gallon (300 liter) Inox reactor, stainless steel construction, approximately 24" diameter x 34" straight side, dish lid top with dish bottom, jacket and interior rated 30 psi and full vacuum at 300 F, 6" top access, with (1) 4", (1) 3", (2) 2" and (2) 1.5" nozzles on top, with bottom entering magnetic agitator, .75 hp with controls, 1.5" center bottom outlet, with load cells, all on portable frame, serial# 95011-2, CRN# K82555, built 1995.
-
Used ACG Pam Mini Filled Capsule Sorter, model MCS100, stainless steel construction, 9" x 12" sorting area, serial# MCS-559.
-
Solid form screening optimizes drug properties by evaluating polymorphs, salts, and cocrystals to improve solubility, stability, and manufacturability using advanced analytics.